Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis

被引:28
|
作者
Vollenberg, Richard [1 ]
Tepasse, Phil-Robin [1 ]
Ochs, Kevin [1 ]
Floer, Martin [2 ]
Strauss, Markus [3 ]
Rennebaum, Florian [1 ]
Kabar, Iyad [1 ]
Rovas, Alexandros [4 ]
Nowacki, Tobias [1 ,5 ]
机构
[1] Univ Hosp Muenster, Dept Med B Gastroenterol Hepatol Endocrinol & Cli, D-48149 Munster, Germany
[2] Klinikum Ibbenburen, Dept Med 1, D-49477 Ibbenburen, Germany
[3] Univ Hosp Muenster, Dept Cardiol Coronary I Peripheral Vasc Dis Heart, D-48149 Munster, Germany
[4] Univ Hosp Muenster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, D-48149 Munster, Germany
[5] Marienhosp Steinfurt, Dept Med Gastroenterol, D-48565 Steinfurt, Germany
来源
VIRUSES-BASEL | 2021年 / 13卷 / 11期
关键词
SARS-CoV-2; COVID-19; syndecan-1; glycocalyx; long-COVID-19; INFECTION;
D O I
10.3390/v13112324
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter for measuring glycocalyx injury. This prospective, multicenter, observational, cross-sectional study analyzed SDC-1 levels in 24 convalescent patients that had been infected with SARS-CoV-2 with mild disease course without need of hospitalization. We included 13 age-matched healthy individuals and 10 age-matched hospitalized COVID-19 patients with acute mild disease course as controls. In convalescent COVID-19 patients, significantly elevated SDC-1 levels were detected after a median of 88 days after symptom onset compared to healthy controls, whereas no difference was found when compared to SDC-1 levels of hospitalized patients undergoing acute disease. This study is the first to demonstrate signs of endothelial damage in non-pre-diseased, convalescent COVID-19 patients after mild disease progression without hospitalization. The data are consistent with studies showing evidence of persistent endothelial damage after severe or critical disease progression. Further work to investigate endothelial damage in convalescent COVID-19 patients should follow.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Convalescent plasma transfusion for pregnant patients with COVID-19
    Mastroianni, Antonio
    Greco, Sonia
    Mauro, Maria Vittoria
    Chidichimo, Luciana
    Vangeli, Valeria
    LANCET MICROBE, 2021, 2 (08): : E350 - E350
  • [42] Use of convalescent plasma in COVID-19 patients in China
    Zhu, M.
    Hu, K.
    Zhu, Z.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2020, 27 (03) : 168 - 169
  • [43] Convalescent plasma (CP) therapy in patients with COVID-19
    Cakir, Banu
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)
  • [44] Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
    Zha, Duoduo
    Fu, Mingui
    Qian, Yisong
    CELLS, 2022, 11 (12)
  • [45] Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19
    Yamaoka-Tojo, Minako
    BIOMEDICAL JOURNAL, 2020, 43 (05) : 399 - 413
  • [46] Hypoxemia in COVID-19 patients: An hypothesis
    Fisher, H. K.
    MEDICAL HYPOTHESES, 2020, 143
  • [47] Statin Therapy, Inflammation, and Outcomes in Patients Hospitalized for COVID-19: A Prospective Multicenter Cohort Study
    Ismail, Anis
    Shadid, Husam R.
    Huang, Yiyuan
    Hutten, Christina G.
    Vasbinder, Alexi
    Pizzo, Ian
    Catalan, Tonimarie Claire
    Diaz, Kristen Machado
    Kunkle, Pennelope
    Banerjee, Mousumi
    Rubenfire, Melvyn
    Brandt, Eric J.
    Williams, Geoffery
    Pop-Busui, Rodica
    Hayek, Salim S.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (12):
  • [48] Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study
    Prata-Barbosa, Arnaldo
    Lima-Setta, Fernanda
    dos Santos, Gustavo Rodrigues
    Lanziotti, Vanessa Soares
    Vieira de Castro, Roberta Esteves
    de Souza, Daniela Carla
    Raymundo, Carlos Eduardo
    Caino de Oliveira, Felipe Rezende
    Peixoto de Lima, Lucio Flavio
    Tonial, Cristian Tedesco
    Colleti Jr, Jose
    Novaes Bellinat, Ana Paula
    Lorenzo, Vivian Botelho
    Zeitel, Raquel de Seixas
    Pulcheri, Lucas
    Monte da Costa, Fernanda Ciuffo
    Ferreira La Torre, Fabiola Peixoto
    das Neves Figueiredo, Elaine Augusta
    da Silva, Thiago Peres
    Riveiro, Paula Marins
    Fonseca da Mota, Isabele Coelho
    Brandao, Igor Bromonschenkel
    Almeida de Azevedo, Zina Maria
    Gregory, Simone Camera
    Oliveira Boedo, Fernanda Raquel
    de Carvalho, Rosana Novais
    de Arnaldo Silva Rodriguez Castro, Natalia Almeida
    Santos Genu, Daniel Hilario
    Krepel Foronda, Flavia Andrea
    Cunha, Antonio Jose Ledo A.
    de Magalhaes-Barbosa, Maria Clara
    JORNAL DE PEDIATRIA, 2020, 96 (05) : 582 - 592
  • [49] Echocardiographic parameters in COVID-19 patients and their association with ICU mortality: a prospective multicenter observational study
    Amarja Ashok Havaldar
    Merugu Vinay Kumar
    Raman Kumar
    Surya Prakash Yarramalle
    Mohammad Saif Khan
    Krushna Chandra Misra
    Shubhangi Kamble
    Atul Sangale
    Jay Prakash
    Munta Kartik
    Sumithra Selvam
    The Ultrasound Journal, 15
  • [50] Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
    Yasin, Ayse Irem
    Aydin, Sabin Goktas
    Sumbul, Bilge
    Koral, Lokman
    Simsek, Melih
    Geredeli, Caglayan
    Ozturk, Akin
    Perkin, Perihan
    Demirtas, Derya
    Erdemoglu, Engin
    Hacibekiroglu, Ilhan
    Cakir, Emre
    Tanrikulu, Eda
    Coban, Ezgi
    Ozcelik, Melike
    Celik, Sinemis
    Teker, Fatih
    Aksoy, Asude
    Firat, Sedat T.
    Tekin, Omer
    Kalkan, Ziya
    Turken, Orhan
    Oven, Bala B.
    Dane, Faysal
    Bilici, Ahmet
    Isikdogan, Abdurrahman
    Seker, Mesut
    Turk, Haci M.
    Gumus, Mahmut
    FUTURE ONCOLOGY, 2022, 18 (10) : 1235 - 1244